Status:
UNKNOWN
Best Bypass Surgery (BBS) Trial
Lead Sponsor:
Rigshospitalet, Denmark
Collaborating Sponsors:
Danish Heart Foundation
The Danish Medical Research Council
Conditions:
Heart Disease
Cardiovascular Disease
Eligibility:
All Genders
55+ years
Phase:
PHASE3
Brief Summary
There is evidence linking cardiopulmonary bypass to negative side effects when used for coronary artery bypass grafting. Coronary artery bypass grafting can be performed without the use of cardiopulmo...
Detailed Description
Objectives: To evaluate the beneficial and harmful effects of off-pump coronary artery bypass grafting (OPCAB) versus conventional coronary artery bypass grafting (CCABG) using a heart- and lung mach...
Eligibility Criteria
Inclusion
- Known ischemic three vessel heart disease affecting one of the marginal coronary arteries
- Age \> 54 years
- Scheduled for elective or subacute CABG
- EuroSCORE \> 4 and \< 17
- The patient has signed written informed consent before randomization and surgery.
Exclusion
- Previous heart surgery
- Ejection fraction \< 30 %
- Unstable preoperative condition, i.e., continuous infusion of inotropics on the day of the operation
- Patient unable to give informed consent.
Key Trial Info
Start Date :
April 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2008
Estimated Enrollment :
341 Patients enrolled
Trial Details
Trial ID
NCT00120991
Start Date
April 1 2002
End Date
July 1 2008
Last Update
March 3 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dept. Cardiothoracic Surgery, Rigshospitalet
Copenhagen, Denmark, 2100